In detail, the abnormal expression of EphB2 was remarkably associated with clinicopathological features, including overall survival, disease-free survival, lymph node metastasis, histological differentiation, tumor grade and stage, reflecting its potential value as a sensitive and effective biomarker for cancer diagnosis, prognosis, and therapy. Here, EPHB2 is linked to neoplasm.